Amwill Health, a company in the Pharmaceuticals industry, reported revenue of ₹23 crore and net profit of ₹4.00 crore for the September 2026 quarter.
Amwill Health (BSE: AMWILL) closed at ₹43.00 on 20 Nov 2026, down 9.3% over the past year. Its market capitalisation is ₹86 crore and it trades at 7.7 times earnings.
Incorporated in 2009, Amwill Health Care is in the wholesale trading of pharmaceutical products
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.